Roche expands hepatitis diagnostics portfolio
Almost 300 million people globally have chronic hepatitis B
Almost 300 million people globally have chronic hepatitis B
First-ever brain chemistry database will allow clinicians to quickly infer brain biomarker data to support the diagnostic process in conditions such as Alzheimer's Disease
The delegation's visit covered a wide range of topics
Research released at UN General Assembly week shows tests predicting heart disease and diabetes are among lowest cost solutions for improving Indian health
The market capitalization of the company stood at Rs. 7,000 crore +
The super-resolution optical technology will accelerate discovery in biomedical research and transform in vitro diagnostics
Cytel excels at using proven quantitative techniques to transform real-world data into actionable insights
The positive safety review from the DSMB enables the trial to move forward as planned, with an estimated completion date in December 2023
Investment enables development of revolutionary multi-omic platform using super-resolution imaging technology for earlier disease detection and accelerated discovery of therapeutics
Subscribe To Our Newsletter & Stay Updated